B019

Phenoxybenzamine hydrochloride

≥97%, powder

• Synonym(s): N-(2-Chloroethyl)-N-(1-methyl-2-phenoxyethyl)benzylamine hydrochloride
• Empirical Formula (Hill Notation): C₁₈H₂₂ClNO · HCl
• CAS Number: 63-92-3
• Molecular Weight: 340.29
• EC Number: 200-569-7
• MDL number: MFCD00055152
• UNSPSC Code: 12352116
• PubChem Substance ID: 24277760
• NACRES: NA.77

Properties

• Quality Level: 100
• Assay: ≥97%
• form: powder
• color: white
• solubility: H₂O: slightly soluble; alcohol: soluble; propylene glycol: soluble
• originator: Wellspring
• storage temp.: 2-8°C
• SMILES string: Cl[H].CC(COc1ccccc1)N(CCCl)Cc2ccccc2
• InChI: 1S/C18H22ClNO.ClH/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17;/h2-11,16H,12-15H2,1H3;1H
• InChI key: VBCPVIWPDJVHAN-UHFFFAOYSA-N
• Gene Information: human ... ADRA1A(148) , ADRA1B(147) , ADRA1D(146) , ADRA2A(150) , ADRA2B(151) , ADRA2C(152)

Description

Biochem/physiol Actions

Calmodulin antagonist; α-adrenoceptor antagonist.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

This compound was developed by Wellspring. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Safety Information

• Pictograms: GHS08,GHS07
• Signal Word: Warning
• Hazard Statements: H302,H351
• Precautionary Statements: P201 - P301 + P312 + P330 - P308 + P313
• Hazard Classifications: Acute Tox. 4 Oral - Carc. 2
• Storage Class Code: 11 - Combustible Solids
• WGK: WGK 3
• Flash Point(F): Not applicable
• Flash Point(C): Not applicable
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves